The global public health crisis caused by COVID-19 has lasted longer than many of us
would have hoped and expected. With its high uncertainty and limited control, the COVID-19 …

Mental disorders account for at least 18% of global disease burden, and the associated
annual global costs are projected to be US $6 trillion by 2030. Evidence-based, cost …

This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

Background Adverse mental health consequences of COVID-19, including anxiety and
depression, have been widely predicted but not yet accurately measured. There are a range …

Importance To date, the association of psychiatric diagnoses with mortality in patients
infected with coronavirus disease 2019 (COVID-19) has not been evaluated. Objective To …

Importance Heterogeneous evidence exists for the association between COVID-19 and the
clinical outcomes of patients with mental health disorders. It remains unknown whether …

Importance Preexisting noncommunicable diseases (eg, diabetes) increase the risk of
COVID-19 infection, hospitalization, and death. Mood disorders are associated with …

Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-
CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at …

Introduction At present, there is limited data on the risks, disparity, and outcomes for COVID‐
19 in patients with dementia in the United States. Methods This is a retrospective case …